Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-19-055045)

Filing Details

Accession Number:
0001209191-19-055045
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-04 19:32:28
Reporting Period:
2019-11-01
Accepted Time:
2019-11-04 19:32:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1269021 Portola Pharmaceuticals Inc PTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187333 Hollings Renton C/O Portola Pharmaceuticals, Inc.
270 East Grand Ave.
South San Francisco CA 94080		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-01 5,000 $9.00 18,194 No 4 M Direct
Common Stock Disposition 2019-11-01 5,000 $30.00 13,194 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2019-11-01 5,000 $0.00 5,000 $9.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2020-04-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,826 Indirect Held by The Renton Family Community Property Trust
Footnotes
  1. The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2019.
  2. The option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on May 29, 2010.